Summary3 H-Sch 58235 was prepared at a specific activity of 29.1 Ci/mmol by Ir(COD)(Cy 3 P)PyPF 6 catalysed exchange with tritium gas.14 C-Sch 58235 was prepared in three steps from p-hydroxy[ring-U-14 C]benzaldehyde with an overall radiochemical yield of 21%. 13 C 6 -Sch 58235 was similarly prepared in three steps from p-hydroxy[ring-U-13 C 6 ]benzaldehyde in an overall yield of 41%.
Vicriviroc or SCH 417690 is a potent and selective antagonist of the CCR5 receptor. CCR5 receptor antagonists have the potential for the treatment of HIV infections. Four distinct isotopically labelled forms of SCH 417690 were synthesized. Low specific activity [(3) H]SCH 417690 was prepared for a preliminary absorption, distribution, metabolism and excretion evaluation of the compound and [(14) C]SCH 417690 for more definitive absorption, distribution, metabolism and excretion work, including an absorption, metabolism and excretion study in man. In addition, high specific activity [(3) H]SCH 417690 was prepared for CCR5 receptor binding work and [(2) H4 ]SCH 417690 was prepared as an internal standard for a liquid chromatography-mass spectrometry bioanalytical method. The paper discusses the synthesis of four isotopically labelled forms of SCH 417690.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.